Author:
Wu Howard H,Eaton Joseph P,Jones Kelly J,Cramer Harvey M,Randolph Melissa L,Post Kristin M,Malek Amanda,Bilbo Sarah,Sen Joyashree D,Chen Shaoxiong,Cheng Liang
Publisher
Springer Science and Business Media LLC
Subject
Pathology and Forensic Medicine
Reference27 articles.
1. Siegel R, Naishadham D, Jemal A . Cancer statistics, 2013. CA Cancer J Clin 2013;63:11–30.
2. Parkin M, Tyczynski JE, Boffetta P et al. Lung cancer epidemiology and etiology In: Travis WD, Brambilla E, Müller-Hermelink HK, et al. (eds). WHO Classification of Tumours: Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart. IARC Press: Lyon, France, 2004, pp 12–25.
3. Fathi AT, Brahmer JR . Chemotherapy for advanced stage non-small cell lung cancer. Semin Thorac Cardiovasc Surg 2008;20:210–216.
4. Ladanyi M, Pao W . Lung adenocarcinoma: guiding EGFR targeted therapy and beyond. Mod Pathol 2008;21 (suppl 2):S16–S22.
5. Suda K, Tomizawa K, Mitsudomi T . Biological and clinical significance of KRAS mutations in lung cancer: an oncogenic driver that contrasts with EGFR mutation. Cancer Metastasis Rev 2010;29:49–60.